The Relationship Between Plasma Gelsolin Levels and Myeloperoxidase in Patients Undergoing Hemodialysis: A Prospective, Observational, Controlled Study

Basit Öğe Kaydı
dc.contributor.authorTural, Haci Huseyin
dc.contributor.authorKose, Kader
dc.contributor.authorGunturk, Inayet
dc.contributor.authorKocyigit, Ismail
dc.contributor.authorYazici, Cevat
dc.date.accessioned2024-11-07T13:32:26Z
dc.date.available2024-11-07T13:32:26Z
dc.date.issued2024
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjective: Given the association of inflammatory conditions with the development of comorbidities, particularly cardiovascular diseases, it is crucial to monitor inflammation in hemodialysis patients. This study aimed to evaluate plasma gelsolin and myeloperoxidase (MPO) levels before and after dialysis sessions and to assess their relationship with inflammation. Materials and Methods: The study included 16 healthy volunteers and 30 patients receiving regular hemodialysis treatment. Along with routine biochemical analyses, plasma gelsolin and MPO levels were measured in blood samples taken from the study group before and after the sessions. Results: Plasma gelsolin levels were found to be statistically higher both before and after dialysis compared to the control group (p=0.000); however, there was no significant change during the session (p=0.094). Conversely, plasma MPO activity, which was significantly higher before dialysis, increased at the end of the session (p=0.000). Conclusion: It can be concluded that elevated levels of gelsolin are associated with a chronic inflammatory response, as indicated by high -sensitivity C -reactive protein (hsCRP) and MPO levels. Consequently, gelsolin could be considered a supportive treatment strategy for these patients.
dc.description.sponsorshipResearch Fund of Erciyes University [TYL-2019-8691]
dc.description.sponsorshipThis study was supported by the Research Fund of Erciyes University (Grant No.TYL-2019-8691) .
dc.identifier.doi10.14744/cpr.2024.83703
dc.identifier.endpage46
dc.identifier.issn2980-2156
dc.identifier.issue1
dc.identifier.startpage41
dc.identifier.urihttps://doi.org/10.14744/cpr.2024.83703
dc.identifier.urihttps://hdl.handle.net/11480/15413
dc.identifier.volume46
dc.identifier.wosWOS:001158049900001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherErciyes Univ Sch Medicine
dc.relation.ispartofJournal of Clinical Practice and Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectHemodialysis
dc.subjectplasma gelsolin
dc.subjectmyeloperoxidase
dc.subjectinflammation
dc.subjectkidney failure
dc.titleThe Relationship Between Plasma Gelsolin Levels and Myeloperoxidase in Patients Undergoing Hemodialysis: A Prospective, Observational, Controlled Study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu